PPP2R2B and breast cancer: In this study, we found that H3K9 trimethylation was the main cause of PPP2R2B silencing in BC, and that the SUV39H1 inhibitor, chaetocin, significantly increased PPP2R2B expression and the sensitivity of BC cells to cisplatin.